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Abstract
Background: Metabolic Syndrome (MS) is prevalant in China, especially according to the pediatric obesity group.
Based on the MS-CHN2012 definition for Chinese children and adolescents the need to explore and establish a
convienent MS screening become imminent. This study aims to investigate the optimal cut-off values, compare the
accuracy for the (TriGlycerides (TG) to High-Density Lipoprotein Cholesterol (HDL-C)) (TG/HDL-C) ratio and Homeostasis
Model Assessment Insulin Resistance (HOMA-IR) indexs to identify Metabolic Syndrome in obese pediatric population
in China.
Method: A total sample of 976 children (female286 male690, BMI > =95percentile) aged from 6–16 years underwent a
medical assessment including a physical examination and investigations of total cholesterol, high-density lipoprotein,
low-density lipoprotein, triglycerides, insulin, glucose, and oral glucose tolerance test to identify the components of
Metabolic Syndrome. The validity and accuracy between TG/HDL-C ratio and HOMA-IR were compared by Receiver
Operating Characteristics analysis (ROC).
Result: TG/HDL-C ratio achieved a larger ROC Area under Curve (AUC = 0.843) than HOMA-IR indexes (0.640, 0.625 for
HOMA1-IR, HOMA2-IR respectively) to screen for Metabolic Syndrome. The cut-off values for MS were: TG/HDL-C
ratio > 1.25 (sensitivity: 80 %; specificity: 75 %), HOMA1-IR > 4.59 (sensitivity: 58.7 %; specificity: 65.5 %) and HOMA2-IR >
2.76 (sensitivity: 53.2 %; specificity: 69.5 %). The results kept robust after stratified by gender, age group and
pubertal stage.
Discussion: TG/HDL-C ratio was a better indicator than the HOMA-IR to screen for a positive diagnosis for MS.
Furthermore, the TG/HDL-C ratio was superior to the HOMA-IR indexes even after the control of possible
confusions from the gender, age group and puberty stage.
Conclusion: TG/HDL-C ratio proved a better index than HOMA-IR in screening for MS in obese children and
adolescents. TG/HDL-C ratio has a discriminatory power in detecting potential MS in the Chinese obese pediatric
population.
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Background
The prevalence of obesity has increased dramatically in
children and adolescents as China is gradually taking its
place as one of the world’s economic giants, it is becom-
ing an important public health problem [1–4]. Metabolic
Syndrome (MS) is not rare in children and adolescents.
Chinese national nutrition and health survey showed
that in the year 2002, the prevalence of MS was 35.2 %
in obese children. Ninety-six percent of obese children
screened positive for one MS component anomaly, and
74.1 % of obese children had 2 or more abnormal com-
ponents [5]. Therefore, it becomes imminent to explore
an accessible and effective tool to screen obese children
for Metabolic Syndrome components.
For a long period anthropometric measurements had
been recognized as the convenient indicators in the pre-
dicting MS [6–10]. Afterwards Homeostasis Model As-
sessment Insulin Resistance (HOMA-IR) indexes have
been advocated for a close relationship with the compo-
nents of MS [11–13]. Nevertheless, controversy exists
over the variety of indexes used when screening for MS
[8, 9, 14]. Recently, a new index called the TriGlycerides
(TG) to High-Density Lipoprotein Cholesterol (HDL-C)
ratio (TG/HDL-C ratio) has been gaining popularity be-
cause of its ability to explain the significant association
with insulin resistance or cardiovascular risk factors in
adults [15–20] and in children [21–23]. To our know-
ledge, few studies have been investigated regarding the
cutoffs between TG/HDL-C ratio and MS during the
childhood [24, 25] . The aim of our study was to investi-
gate the optimal cutoffs of TG/HDL-C ratio, HOMA-IR




This was a cross-sectional study. Study quality was
assessed according to the checklist of STARD (STAn-
dards for the Reporting of Diagnostic accuracy studies).
1 069 Obese children and adolescents between 6 and
16 years old, of both genders (female 443, male 626),
consecutively registered at the inpatient ward from our
clinic, the Children’s Hospital of Zhejiang University
School of Medicine– Hangzhou, in China, between May
2007 and June 2013, were invited to participate in the
study. A total of 976 (female286 male690) obese school-
children with complete record were eligibly included in
the current study. the Age- and sex-specific Body Mass
Index (BMI) percentiles, developed by the Working
Group for Obesity in China, were used to classify partic-
ipants as obese (BMI ≥ 95 %) [26]. The exclusion criteria
were as follows: the known presence of diabetes or high
blood pressure, the use of drugs which influence glucose
or lipid metabolism (glucocorticoid), specific causes of
endocrine or genetic obesity, low birth weight, distress
during blood sampling or a difficult phlebotomy (more
than 5 min) as well as menstrual cycle changes that indi-
cate the presence of Polycystic Ovary Syndrome in female
participants. Signed informed consent was obtained from
participants and or parents or guardians. The study was
approved by the Research Ethics Committee of the chil-
dren’s hospital of Zhejiang University School of Medicine.
The MS definition in age group was chosen by the MS-
CHN2012 definition [27, 28] for all ages by The Chinese
Medical Association in 2012 [29].
Clinical and anthropometric measurements
Subjects’ height and weight were measured according to
our standard protocol [30]. BMI was calculated as weight
(kg) divided by height squared (m2). Waist Circumference
(WC) was measured midway between the lowest rib and
the top of the iliac crest. The mean of two measurements
made at the end of a normal expiration was used in the
analyses. Two measurements of right arm systolic and dia-
stolic blood pressure (SBP and DBP) were performed
three times 10 min apart and the mean values of the latter
two measurements were recorded. Pubertal development
was assessed by Tanner stage of breast development in
girls and testicular volume in boys. This assessment was
performed visually by two pediatricians of the same gen-
der as the child.
Laboratory assays
Venous blood samples were collected after an overnight
(≥12 h) fast. Subjects also underwent an oral glucose toler-
ance test (OGTT; 1.75 g of glucose solution per kg, max-
imum 75 g). The samples were centrifuged, aliquoted and
immediately frozen for future analysis in blind of the clin-
ical information. Blood samples were also analyzed for con-
centrations of plasma glucose, triglycerides (TG), total
cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C) and
insulin. Serum lipids (enzymatic methods) and plasma glu-
cose (glucose oxidase method) were assayed using the
Modular DPP automatic biochemistry analysis system
(Roche, Rotkreuz, Switzerland). HDL-C and LDL-C were
measured directly. Insulin was determined by chemilumin-
escent micro particle immunoassay (Abbott Park, IL 60064
UK), developed in the key Laboratory at the Children’s
Hospital which had an inter-assay coefficients of variation
of <9.0 % and no cross-reactivity to proinsulin (<0.05 %).
Definitions of MS and HOMA-IR calculation
In this study the presence of pediatric Metabolic Syndrome
(MS) was determined according to the MS-CHN2012 MS
definition [28] for the > =10 years of age group. a diagnosis
of MS was made as the presence of abdominal obesity
(WC ≥ 90th percentile for age and gender) plus the
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presence of two or more of the following components: ele-
vated TG (≥1.47 mmol/L), low HDL-C (<1.03 mmol/L),
high blood pressure (systolic ≥130 mmHg or diastolic
≥85 mmHg), and elevated blood glucose (≥5.6 mmol/L).
For the <10 years of age group the MS definition by the So-
ciety of Pediatrics, Chinese Medical Association in 2012
(MS-CHN2012) [29, 31] was used where elevated blood
glucose includes impaired fasting glucose and impaired glu-
cose tolerance according to American Diabetes Association
classifications [32] as fasting plasma glucose of ≥5.6 to
6.9 nmol/l, and as 2-h post-OGTT glucose of ≥7.8 to
11.0 nmol/l respectively, finally the family hsitory of meta-
bolic syndrome, type 2 diabetes mellitus, dyslipidaemia, car-
diovascular disease, hypertension was investigated. Insulin
resistance index was calculated by homeostasis model as-
sessment of insulin resistance (HOMA1-IR) as (fasting
insulin mU/L) × (fasting glucose mmol/L)/22.5 [33] and the
HOMA2-IR index was obtained by the program HOMA
Calculator v2.2.2 at http://www.dtu.ox.ac.uk/homacalcula-
tor/index.php.
Statistical analysis
Data was reported as median (interquartile range), and
comparisons were performed using Mann–Whitney U test.
A sample of 26 from the MS group and 26 from the Non-
MS group achieved 90 % power to detect a difference of 0.2
between a diagnostic test with a Receiver Operating Char-
acteristic (ROC) Area Under the Curve (AUC) of 0.8, and
alterative diagnostic test with an AUC of 0.6 using a two-
sided Z-test at a significance level of 0.05, The correlation
between the two diagnostic tests is assumed to be 0.6.
Prevalence of individual metabolic abnormalities of differ-
ent groups was compared using the Chi-square test or Fish-
er’s exact test as appropriate. A receiver operating
characteristic (ROC) curve was generated for the total stud-
ied population. The areas under the ROC curve (AUC)
were calculated to evaluate the accuracy of the indicators
by nonparametric method. The greater the AUC, the
greater the discriminatory power of them for MS. The opti-
mal cut-off value was denoted by the value that had the ac-
ceptable sensitivity, specificity and the closest point to the
upper left corner of the ROC curve, which is often selected
as the best combination of true-positive rate and false-
positive rate [34]. The Z statistic pairwise comparison was
used to compare the AUC. Statistical programs available in
SAS for Windows (SAS Release 9.2 Cary, NC, USA) were
used in this analysis, P < 0.05 was defined significance.
Results
Clinical Characteristics and metabolic phenotypes of all
sample
1 069 Obese children and adolescents of both genders
(female 443, male 626) aged from 6-16years were regis-
tered in this study. A total of 42 subjects were excluded
because they did not satisfy inclusion criteria (31 with
difficult blood sampling, 11 with a low birth weight).
Other exclusions were twelve subjects diagnosed with
early-onset type 2 diabetes mellitus, nine with distress
during BP monitoring, twenty with missing data in clin-
ical or laboratory records and ten who refused to partici-
pate. Finally 976 participants were included in the
analysis datasets. According to the MS diagnosis, overall
our study showed that around 25.8 % of the 976 children
and adolescents analyzed presented the syndrome, which
was more prevalent in larger than 10-year-age obese in-
dividuals, especially those at puberty stage. But no differ-
ence was found between genders (Table 1).
The basic characteristics of the MS and Non-MS in the
children and adolescents that were eligible for this investi-
gation are stratified by the sex, age group and pubertal
stage. The MS group individals were elder, had higher
BMI than the Non-MS group. The lipid profile can be
seen in Table 2. An atherogenic profile was noticed in the
MS group with higher LDL-C, lower HDL-C, higher TG,
higher HOMA-IR, and higher TG/HDL-C values and the
differences were found significant between MS and non-
MS groups. For the HOMA-IR and the TG/HDL-C, stat-
istical significant can also be found among the sex, age
strata and pubertal stage groups (Table 3).
Receiver operating characteristics analyses
The TG/HDL-C ratio was a better predictor of MS (ac-
ceptable sensitivity and specificity and higher AUC-ROC)
than either HOMA1-IR or HOMA2-IR. The cut-off values
for MS were: TG/HDL-C ratio > 1.25 (sensitivity: 80 %;
specificity: 75 %), HOMA1-IR > 4.59 (sensitivity: 58.7 %;
specificity: 65.5 %) and HOMA2-IR > 2.76 (sensitivity:
53.2 %; specificity: 69.5 %). After stratified by age group,
puberty stage and sex, the cutoffs of HOMA1-IR changed
from 3.58–5.74 while the cutoffs of HOMA2-IR fluctuated
from 1.92–2.99. However the cutoffs of TG/HDL-C varied
slightly from 1.21–1.53. The Overall AUC-ROC values for
the prediction of MS were 0.640, 0.625, and 0.843 by
Table 1 Prevalence of the 976 obese children for MS
strata Non-MS MS Total
Sex
FEMALE 213 74.5 % 73 25.5 % 286
MALE 511 74.1 % 179 25.9 % 690
Age group*
<10 years 281 80.5 % 68 19.5 % 349
> = 10 years 443 70.7 % 184 29.3 % 627
Pubertal stage*
Pre-pubertal 372 81.2 % 86 18.8 % 458
Pubertal 352 68.0 % 166 32.0 % 518
MS Metabolic Syndrome, *Comparison by Chi-square P < 0.05
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HOMA1-IR, HOMA2-IR and TG/HDL-C respectively.
Significant difference of the AUC-ROC values between
HOMA-IR and TG/HDL-C was found with a higher sen-
sitivity and specificity. When stratified by age group, gen-
der and puberty stage the AUC-ROC values for the
prediction by HOMA-IR were still lower than those by
TG/HDL-C.
Figure 1 represents the age group, pubertal stage and
sex-specific ROC curve analyses, respectively. The ROC
curves visually represent the relationship between sensi-
tivity (true positive rate) and 1-specificity (false positive
rate) over the entire range of the index value. All the
curves (Fig. 1) were significantly greater than what were
expected by chance stratification by the age group, pu-
berty stage and sex. Analysis of the data indicated sig-
nificant differences in ROC curves, with TG/HDL-C
performing reasonably better than HOMA1-IR or
HOMA2-IR in identifying MS in obese adolescents, and
no difference in ROC curves were found between
HOMA1-IR and HOMA2-IR (p > 0.05).
Discussion
The present study investigated the optimal cut-off values
for TG/HDL-C ratio, and HOMA-IR indexes to identify
MS in a pediatric obese population. It was also demon-
strated that the TG/HDL-C ratio was a better indicator
than the HOMA-IR to screen for a positive diagnosis for
MS. Furthermore, it was verified that the TG/HDL-C ra-
tio was superior to the HOMA-IR indexes even after the
control of possible confusions from the gender, age
group and puberty stage.
Previous studies demonstrated that the HOMA-IR in-
dexes were a good indicator in identifying insulin resist-
ance and MS in children [22, 23] and in adults [20]. But
the inconvenience was only a specific range of values are
acceptable for calculation. In clinical practice, this limi-
tation complicates the management of insulin results
outside the limits and a computer is needed to run the
program [25]. Newly published papers revealed that TG/
HDL-C ratio makes a significant contribution to the
components of the MS [21], but no further investigation
Table 2 Summary characteristics for clinical and metabolic variables categorized by the status of MS
Non-MS(n = 724) MS(n = 252)
Median P 25 P75 Median P25 P75
Age, years 10.5 8.83 12 11.62 9.79 12.83
BMI, kg/m2 27.3 25.01 29.9 28.92 26.39 32.24
Systolic blood pressure, mmHg 114 105 122 126 112 135
Diastolic blood pressure, mmHg 67 61 72 70 65 78
Triglyceride, mg/dL 1.09 0.84 1.46 1.8 1.34 2.22
HDL cholesterol, mg/dL 1.24 1.1 1.43 0.96 0.85 1.06
TG/HDL-C 0.9 0.63 1.26 1.85 1.34 2.42
LDL cholesterol, mg/dL 2.34 2 2.74 2.55 2.21 3.03
Fasting plasma glucose, mg/dL 5.2 4.8 5.4 5.5 5 5.8
Fasting plasma insulin, mU/L 16.3 10.7 23.7 22 13.2 31.6
HOMA1-IR 3.67 2.39 5.48 5.42 3.23 7.58
HOMA2-IR 2.1 1.4 3.01 2.86 1.73 4.02
MS Metabolic Syndrome, BMI body mass index, TG triglyceride, HDL-C HDL-cholesterol, LDL-C LDL-cholesterol, P25 percentile 25, P75 percentile 75, statistical
significance were found in all the variables between the MS and Non-MS by Mann–Whitney test p < 0.05
Table 3 HOMA-IR and TG/HDL-C categorized by sex, age group and pubertal stage
strata HOMA1-IR* HOMA2-IR* TG/HDL-C*
N Median P25 P75 N Median P25 P75 N Median P25 P75
Sex female 286 4.22 2.66 6.94 286 2.33 1.52 3.64 286 1.08 .72 1.73
male 690 3.90 2.47 5.87 690 2.17 1.44 3.16 690 1.05 .67 1.58
Age group <10 years 349 3.20 2.11 4.64 349 1.76 1.18 2.52 349 .95 .65 1.49
> = 10 years 627 4.55 2.96 7.00 627 2.50 1.70 3.73 627 1.13 .71 1.68
pubertal stage Pre-pubertal 458 3.56 2.26 5.05 458 2.01 1.27 2.81 458 .94 .64 1.46
Pubertal 518 4.62 2.87 7.27 518 2.55 1.62 3.88 518 1.18 .76 1.77
P25 percentile 25, P75 percentile 75, *statistical significance were found between strata by Mann–Whitney test p < 0.05
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Fig. 1 ROC comparisons of HOMA-IR and TG/HDL-C stratified by sex, age group and pubertal stage. AUC-ROC Z statistic for pairwise comparison
of AUC: HOMA1-IR = HOMA2-IR, p > 0.05; HOMA1-IR < TG/HDL-C, p < 0.05; HOMA2-IR < TG/HDL-C, p < 0.05; When stratified by sex a female, b male;
age group c (<10 years), d (> = 10 years); pubertal stage (pre-pubertal stage) (e), (pubertal stage) (f)
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had been made to comprehensively develop its associ-
ation with the screening for MS in Chinese pediatric
obesity. In our study the AUC-ROC values (higher
than0.8) of TG/HDL-C ratio were much more robust
than HOMA-IR indexes and were not much influenced
by the pubertal stage. These features make the TG/
HDL-C ratio indicator outstanding from other indicators
for screening for MS in obese pediatric population.
The TG/HDL-C ratio’s optimal cut off value to screen
for MS is reasonable in obese children as the definition
of the MS is the high amount of abdominal fat plus two
of the four components including the Triglyceride and
HDL cholesterol. So there is a high probability to be di-
agnosed as having MS. However, the optimal ratio of
Triglyceride and HDL cholesterol can make a significant
discrimination [35] to MS, when TG/HDL-C ratio in-
creased, the trend toward smaller HDL size was obvious,
which indicated that the maturation of HDL might be
impeded and the reverse cholesterol transport might be
weakened [35] and this imbalance of the ratio may reveal
the complexity of the metabolic processing. The rela-
tionship between TG/HDL-C and MS might be different
according to the sex, age and race/ethics due to the dif-
ferent components contributions of MS is depondent on
the sex, age and race/ethics. In African-American men,
the recommended TG/HDL-C threshold is valid, while
In African-American women, the failure of the TG/
HDL-C ratio to predict insulin resistance occurred prob-
ably due to normal TG levels rather than high HDL-C
levels and it is more likely that the African-American
women with the metabolic syndrome are to have low
HDL-C levels than elevated TG levels based on the ob-
servation [36]. Another study suggested that the TG/
HDL-C ratio was significantly higher in older women
than in younger women, while the ratio was comparable
in younger and older men [20]. In our study, the differ-
ence of TG/HDL-C between sex, age group and pubertal
stage had statistical significance, Female and age group
of less than 10 years may have a higher cutoff (1.44, 1.53
respectively) than the overall cutoff. We found a cutoff
at 1.25 with a sensitivity of 80 % and specificity of 75 %
for TG/HDL-C to screen for MS in Chinese obese chil-
dren. However, further longitudinal study should be per-
formed to confirm if TG/HDL-C has the advantages [23]
of not being age-specific, sex, and is independent of pu-
bertal stage in the Chinese children population.
One limitation of our study might be a potential bias
caused by inconsistent measurements of Triglyceride and
HDL cholesterol, because only data from patients in only
one center with obesity and concomitant diseases are in-
cluded in this study. Other bias with regard to the study
population from a cross-sectional study may also have oc-
curred; therefore the result may lack direct causality. Meth-
odological aspects, such as biochemical measurements are
more difficult to standardize in several years and the study
result was accomplished only in one center, may contribute
to the possible bias. However, experienced pediatricians
and team staff in cooperation can make sure to comply
with standardized procedures in anthropometric parameter
measurement, analytical methodology and lab workup,
which should make results from different year data
comparable.
Conclusion
This study demonstrates that TG/HDL-C ratio for screen-
ing MS may be a better index than HOMA-IR in screen-
ing obese children and adolescents with pediatric MS. We
suggest that the accessible, effective and methodologically
simple assessment of TG/HDL-C ratio might be powerful
in detecting the early stage of potential MS in Chinese
obese children and adolescents although further longitu-
dinal study is needed to confirm the result.
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